Educational evidence summaries. No dosing, sourcing, or treatment instructions.
The Endocrine Evidence Desk reviews GH, GHRH, IGF-1 and ghrelin-receptor mechanisms using primary research and regulatory sources.
54 published notesAn evidence-led Modified GRF (1-29) review focused on glucose and metabolic context, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence DeskAn evidence-led Modified GRF (1-29) review focused on recovery and injury claims, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence DeskAn evidence-led Modified GRF (1-29) review focused on small-study statistics, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence DeskAn evidence-led Modified GRF (1-29) review focused on combination evidence test, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence DeskAn evidence-led Modified GRF (1-29) review focused on wada and sport rules, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence DeskAn evidence-led Modified GRF (1-29) review focused on fda status explained, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence DeskAn evidence-led Modified GRF (1-29) review focused on product identity and purity, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence DeskAn evidence-led Modified GRF (1-29) review focused on safety signal review, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence DeskAn evidence-led Modified GRF (1-29) review focused on human trial design, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk